In Silico Screening of Multi-Domain Targeted Inhibitors for PTK6: A Strategy Integrating Drug Repurposing and Consensus Docking
Protein tyrosine kinase 6 (PTK6), also known as breast tumor kinase (BRK), serves as a non-receptor intracellular tyrosine kinase within the Src kinases family. Structurally resembling other Src kinases, PTK6 possesses an Src homology 3 (SH3) domain, an Src homology 2 (SH2) domain, and a tyrosine ki...
Saved in:
Main Authors: | Yujing Zhou (Author), Ming Wah Wong (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
by: Yogesh Kumar, et al.
Published: (2020) -
Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies
by: Ashraf K. El-Damasy, et al.
Published: (2024) -
Discovery of potential cyclooxygenase inhibitors using in silico docking studies
by: Arumugam Madeswaran, et al.
Published: (2012) -
In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach
by: Muthu Kumar Thirunavukkarasu, et al.
Published: (2021) -
Discovery of potential cholesterol esterase inhibitors using in silico docking studies
by: Thirumalaisamy Sivashanmugam, et al.
Published: (2013)